View Older Stories View More Recent Stories
-
Nexteer's High Mount Direct Drive Actuator Unlocks Cockpit Design Freedom for Software-Defined Vehicles
-
Senmiao signs letter of intent for Utah data center campus deal
-
Irina Heaver, UAE Crypto Lawyer, Named Among the Top Women of Influence 2026 by Inc. Arabia, NeosLegal Announces
-
B.Riley Upgrades Compass Diversified (CODI) to Buy, 'More Constructive Outlook Set Up 2027'
-
Tenax Therapeutics (TENX) PT Lowered to $4 at Guggenheim
-
Septerna Inc (SEPN) PT Raised to $51 at Guggenheim
-
UBS Starts Amcor Plc. (AMCR) at Buy
-
BridgeBio Pharma (BBIO) PT Raised to $102 at Wells Fargo
-
Cardinal Infrastructure Group Inc. (CDNL) Misses Q2 EPS by 2c ; Offers Guidance
-
Axsome Therapeutics (AXSM) PT Raised to $275 at Guggenheim
-
Oman and Iran in advanced stage of Hormuz talks, Qatar says
-
Metagenomi Inc (MGX) PT Lowered to $7 at Wells Fargo
-
McKesson (MCK) PT Raised to $933 at Wells Fargo
-
Invesco AUM falls 0.9% to $2.45 trillion in July 2026
-
Morgan Stanley notes India equity inflows fell in July
-
The Pennant Group (PNTG) PT Raised to $46 at Wells Fargo
-
H.C. Wainwright Reiterates Buy Rating on Archer Aviation Inc. (ACHR)
-
Axsome Therapeutics (AXSM) PT Raised to $256 at Wells Fargo
-
H.C. Wainwright Reiterates Buy Rating on Surf Air Mobility Inc (SRFM)
-
Wells Fargo on NVIDIA (NVDA) Debt: 'We see this as yet another example of how NVDA is playing a much bigger game'
-
Olema Pharmaceuticals (OLMA) PT Lowered to $36 at H.C. Wainwright
-
Agenus Inc. (AGEN) PT Lowered to $25 at H.C. Wainwright
-
Nkarta Inc. (NKTX) PT Lowered to $14 at H.C. Wainwright
-
Innate Pharma S.A. (IPHA) PT Raised to $7 at H.C. Wainwright
-
Eton Pharmaceuticals (ETON) PT Raised to $65 at H.C. Wainwright
-
On Holding shares fall sharply after Q2 sales miss
-
S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
-
BofA: AI adoption shows limited impact on overall job growth
-
Citi bullish on MongoDB stock, expects 'significant positive estimate revisions'
-
Why Wednesday's inflation print could provide the next dovish catalyst
-
JPMorgan Resumes Take-Two Interactive (TTWO) at Overweight
-
H.C. Wainwright Reiterates Neutral Rating on Crinetics (CRNX)
-
Cardinal Health (CAH) Tops Q4 EPS by 19c, Misses on Revenue; Offers FY27 EPS Guidance
-
Wolfe Research says AI productivity gains won't solve U.S. debt
-
ArrowXL cuts fleet mileage 13% using Descartes route planning tool
-
Jacobs wins $750M Utah canal modernization contract
-
Blue Moon Metals acquires 33 tungsten and antimony projects in the West
-
Twenty One Capital CEO outlines five strategic priorities for Bitcoin firm
-
BofA raises obesity market forecast on Lilly stock international strength
-
Fluent Inc. (FLNT) PT Raised to $4.50 at Canaccord
-
Bernstein notes TSA traffic improvement reflects easy comps, not demand
-
Canaccord Reiterates Buy Rating on Hims and Hers (HIMS)
-
BofA cites AI exposure as convertible bonds outperform stocks
-
Immunic Inc. (IMUX) Tops Q2 EPS by 43c
-
Rapid7 (RPD) PT Raised to $12 at Stephens
-
Sea Ltd. (SE) Misses Q2 EPS by 13c
-
DarioHealth (DRIO) Tops Q2 EPS by 40c
-
Citi upgrades Everpure to Buy, raises price target to $118
-
Oppenheimer Reiterates Perform Rating on Plug Power (PLUG)
-
ATB Capital Markets Upgrades Calfrac Wells Services Ltd. (CFW:CN) (CFWFF) to Outperform (1)
